ArticleFrontiers in human neuroscience2026
Case Report: A novel use of Transcranial Pulse Stimulation in refractory Restless Legs Syndrome.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Restless Legs Syndrome (RLS) is a sensorimotor disorder characterized by an irresistible urge to move the legs. When resistant to pharmacological and psychotherapeutic treatments, RLS remains highly debilitating. This case study represents the first documented case of Transcranial Pulse Stimulation (TPS) applied in treatment-resistant RLS, exploring its feasibility, tolerability, and potential clinical effects. Methods: A 56-year-old male diagnosed with RLS with severe, persistent bilateral leg restlessness and neuropathic cramping pain underwent six sessions of TPS target cortical and subcortical network hubs within the Functional Network-Oriented Neuromodulation (FNON) framework. Results: At six-week follow-up, the patient reported improved sleep, a 95.2% reduction in RLS severity, a 66.7% decrease in pain/discomfort, and a 25% improvement in overall health status. Depression/Anxiety symptoms decreased by 25% while mobility and self-care remained stable at normal levels. Conclusion: In this single case, TPS was well tolerated and associated with meaningful symptomatic improvement. While no conclusions regarding safety or efficacy can be drawn from an individual observation, these findings suggest that TPS may warrant further investigation as non-invasive neuromodulatory approach for refractory RLS. This report expands the scientific literature by introducing a novel network-based neuromodulation modality to the RLS field and provides a foundation for future controlled studies to validate efficacy and optimize stimulation protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.